BridgeBio Pharma (BBIO) Moves 14.6% Higher: Will This Strength Last? Posted byZacks Equity Research January 3, 2022 Leave a comment on BridgeBio Pharma (BBIO) Moves 14.6% Higher: Will This Strength Last? BridgeBio Pharma (BBIO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price…